Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?
- PMID: 36495480
- DOI: 10.1111/bju.15945
Diagnostic evaluation of upper tract urothelial carcinoma: can we safely omit diagnostic ureteroscopy?
Abstract
Objective: To identify clinicopathological or radiological factors that may predict a diagnosis of upper urinary tract urothelial cell carcinoma (UTUC) to inform which patients can proceed directly to radical nephroureterectomy (RNU) without the delay for diagnostic ureteroscopy (URS).
Patients and methods: All consecutive patients investigated for suspected UTUC in a high-volume UK centre between 2011 and 2017 were identified through retrospective analysis of surgical logbooks and a prospectively maintained pathology database. Details on clinical presentation, radiological findings, and URS/RNU histopathology results were evaluated. Multivariate regression analysis was performed to evaluate predictors of a final diagnosis of UTUC.
Results: In all, 260 patients were investigated, of whom 230 (89.2%) underwent URS. RNU was performed in 131 patients (50.4%), of whom 25 (9.6%) proceeded directly without URS - all of whom had a final histopathological diagnosis of UTUC - and 15 (11.5%) underwent RNU after URS despite no conclusive histopathological confirmation of UTUC. Major surgery was avoided in 77 patients (33.5%) where a benign or alternative diagnosis was made on URS, and 14 patients (6.1%) underwent nephron-sparing surgery. Overall, 178 patients (68.5%) had a final diagnosis of UTUC confirmed on URS/RNU histopathology. On multivariate logistic regression analysis, a presenting complaint of visible haematuria (hazard ratio [HR] 5.17, confidence interval [CI] 1.91-14.0; P = 0.001), a solid lesion reported on imaging (HR 37.8, CI = 11.7-122.1; P < 0.001) and a history of smoking (HR 3.07, CI 1.35-6.97; P = 0.007), were predictive of a final diagnosis of UTUC. From this cohort, 51 (96.2%) of 53 smokers who presented with visible haematuria and who had a solid lesion on computed tomography urogram had UTUC on final histopathology.
Conclusion: We identified specific factors which may assist clinicians in selecting which patients may reliably proceed to RNU without the delay of diagnostic URS. These findings may inform a prospective multicentre analysis including additional variables such as urinary cytology.
Keywords: #uroonc; #utuc; CT urography; UTUC; UUTUC; diagnosis; diagnostic ureteroscopy; pathway; upper urinary tract urothelial cell carcinoma.
© 2022 BJU International.
Comment in
-
Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.J Urol. 2023 Oct;210(4):715-716. doi: 10.1097/JU.0000000000003630. Epub 2023 Aug 1. J Urol. 2023. PMID: 37527370 No abstract available.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin 2017; 66: 7
-
- Janisch F, Shariat SF, Baltzer P et al. Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis. World J Urol 2019; 38: 1165-75
-
- Russell B, Liedberg F, Khan MS et al. A systematic review and meta-analysis of delay in radical cystectomy and the effect on survival in bladder cancer patients. Eur Urol Oncol 2020; 3: 239-49
-
- EAU Guidelines on Upper Urinary Tract Urothelial Carcinoma 2022. In European Association of Urology Guidleines. 2022 Edition. Available at: http://uroweb.org/guideline/upper-urinary-tract-urothelial-cell-carcinoma. Accessed October 17, 2022.
-
- Stewart G, Bariol SV, Grigor KM, Tolley DA, McNeill SA. A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU Int 2005; 95: 791-3
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical